Braidwell | News

Alex Karnal recording Invest Like the Best

MediaApril 21, 2026

Alex Karnal on Invest Like the Best

Braidwell Co-Founder and Chief Investment Officer Alex Karnal shares his insights on the future of healthcare.

The conversation covers a range of topics including the emerging opportunity at the intersection of AI and drug development and how each of us might think about driving our own personal Health Stack.

Watch at Invest Like the Best

Sort

2026

APR 17LinkedIn

Designing healthcare from the patient back

View on LinkedIn

APR 16Media

Leadership in an Uncertain World

Watch at Semafor

APRLinkedIn

Advancing AI-driven discovery at ICLR 2026

View on LinkedIn

APRLinkedIn

Biotech capital markets regain strength with dual-tranche financings

View on LinkedIn

APRLinkedIn

Navigating the next wave of peptide therapies

View on LinkedIn

APRLinkedIn

Building brain resilience through the health stack

View on LinkedIn

APRLinkedIn

AI reshapes the future of investing

View on LinkedIn

MAR 11Media

Brian Kreiter and Alex Karnal, Co-Founders of Braidwell

Reuters: ‘Braidwell, Karnal and Kreiter’s AI healthcare fund, surged 28% last year’

Read at Reuters

MAR 9Announcement

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

MARLinkedIn

Building the infrastructure for AI-driven drug discovery

View on LinkedIn

MARLinkedIn

From scientific superintelligence to real-world health outcomes

View on LinkedIn

MARLinkedIn

A “Napster moment” for healthcare access

View on LinkedIn

MARLinkedIn

Expanding the frontier of scientific discovery through AI

View on LinkedIn

MARLinkedIn

Rethinking GLP-1s as durable health infrastructure

View on LinkedIn

MARLinkedIn

AI as a co-pilot for proactive, continuous care

View on LinkedIn

FEBLinkedIn

Expanding access to the modern health stack

View on LinkedIn

FEBLinkedIn

Supporting communities through NeighborShare

View on LinkedIn

FEBPerspective

Life sciences leveraged lending market update

FEBLinkedIn

Rethinking AI for small-molecule discovery

View on LinkedIn

FEBLinkedIn

Building the health stack to close the longevity gap

View on LinkedIn

FEBLinkedIn

Rare pediatric PRV program reauthorized through 2029

View on LinkedIn

JAN 13Announcement

Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines

JAN 11Announcement

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

JANLinkedIn

The rise of PRVs as a non-dilutive financing tool

View on LinkedIn

JANLinkedIn

Proximity-driven innovation in hearing health

View on LinkedIn

JANLinkedIn

Strengthening U.S. leadership in biotechnology

View on LinkedIn

JANLinkedIn

Solving for persistence in healthcare

View on LinkedIn

JANLinkedIn

Investing in Proxima to advance proximity-based therapeutics

View on LinkedIn

JANLinkedIn

AI in drug discovery enters its infrastructure moment

View on LinkedIn

JANLinkedIn

AI for chemistry at an ImageNet inflection point

View on LinkedIn

2025

DEC 10Announcement

Impulse Dynamics Completes $158M Financing Round

DECPerspective

Five themes from NeurIPS on AI in scientific discovery

DECAnnouncement

Partnering to advance heart failure treatment

DECLinkedIn

Supporting the future of public health at Yale

View on LinkedIn

DECLinkedIn

Exploring the future of prevention at Vanderbilt

View on LinkedIn

DECLinkedIn

Biotech competition with China comes into focus

View on LinkedIn

DECLinkedIn

Prioritizing healthspan in the age of longevity

View on LinkedIn

NOVLinkedIn

Cigna moves to eliminate drug rebates

View on LinkedIn

NOVLinkedIn

The role of public funding in advancing AI innovation

View on LinkedIn

NOVLinkedIn

Preserving U.S. leadership in biotechnology

View on LinkedIn

OCT 20Announcement

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

OCTLinkedIn

Advancing science and patient-centered innovation

View on LinkedIn

OCTLinkedIn

Health innovation at a global inflection point

View on LinkedIn

OCTAnnouncement

Lila Sciences closes $350M Series A

SEPWhy We Invested

Why we're investing in Lila Sciences

SEP 15Media

Lila Sciences raises $235M to accelerate AI-driven discovery

Read at Endpoints News

SEPAnnouncement

Partnering with Lila Sciences to reimagine scientific discovery

SEPLinkedIn

Redefining outcomes in cancer care through innovation

View on LinkedIn

JULLinkedIn

Scaling experimentation for AI-driven biology

View on LinkedIn

JULLinkedIn

Advancing AI in structural biology and drug discovery

View on LinkedIn

JULLinkedIn

AI infrastructure as the foundation for next-generation discovery

View on LinkedIn

JUNLinkedIn

Caris Life Sciences completes successful IPO

View on LinkedIn

JUNLinkedIn

Advancing one-time treatments for cardiovascular disease

View on LinkedIn

MAYLinkedIn

Advancing biomolecular design at the intersection of AI and biology

View on LinkedIn

APR 7Announcement

Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion

APRLinkedIn

Caris Life Sciences closes growth financing to advance precision medicine

View on LinkedIn

APRLinkedIn

Bringing AI and biology together at ICLR 2025

View on LinkedIn

FEB 18Announcement

Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection

JAN 9Announcement

Timberlyne Therapeutics Launches with a $180 Million Series A Financing

JANLinkedIn

A turning point for AI in drug discovery

View on LinkedIn

2024

OCTLinkedIn

Nobel Prize recognizes breakthroughs in AI-driven biology

View on LinkedIn

SEP 12Announcement

Oruka Therapeutics Announces $200 Million Private Placement

SEPLinkedIn

AI-designed drug shows promising clinical progress

View on LinkedIn

SEPLinkedIn

AlphaProteo advances AI-driven protein design

View on LinkedIn

AUG 5Announcement

OrthoPediatrics Corp. Announces Private Financing

APR 16Announcement

Cullinan Therapeutics Announces Oversubscribed $280 Million Private Placement

MAR 11Announcement

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

JAN 8Announcement

iRhythm Technologies Closes $150M Non-Dilutive Debt Facility with Braidwell LP

2023

DEC 12Announcement

Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing

NOV 30Announcement

Nevro Announces Acquisition of Vyrsa Technologies

JUN 22Announcement

Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement

JAN 19Announcement

Caris Life Sciences Raises $400 Million in Senior Secured Debt

JAN 9Announcement

ATEC Announces Closing of $150M Flexible, Non-Dilutive Debt Facility with Braidwell LP

JAN 5Announcement

Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline

2022

MAY 4Announcement

DBV Technologies Completes $15.3 Million ADS Sale to Braidwell LP

2021

AUG 31Announcement

Texas Medical Center Launches World's Largest Life Science Campus